Form 4 Filing for Aquestive Therapeutics, Inc.

This filing reports a stock option grant to Julie Krop, a director at Aquestive Therapeutics, Inc. The option, for 50,500 shares of Common Stock, has an exercise price of $3.99 and an expiration date of June 10, 2036. The shares underlying the options vest 100% on June 10, 2027, contingent upon Dr. Krop's continuous service. The filing also includes a Power of Attorney document, authorizing specific individuals to execute and file necessary forms (including Forms 3, 4, and 5) on behalf of the undersigned, related to Section 16 of the Exchange Act and Rule 144. This Power of Attorney remains effective until the undersigned is no longer required to file such forms or until earlier revoked.